...
首页> 外文期刊>Journal of assisted reproduction and genetics >No association of TAP1 and TAP2 genes polymorphism with risk of cervical cancer in north Indian population.
【24h】

No association of TAP1 and TAP2 genes polymorphism with risk of cervical cancer in north Indian population.

机译:在印度北部人群中,TAP1和TAP2基因多态性与子宫颈癌的风险没有关联。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Transporter associated with antigen processing (TAP), a member of the ATP-binding cassette transporter super family, is composed of two integral membrane proteins, TAP-1 and TAP-2. The TAP gene product is involved in the processing of endogenous peptides that bind to MHC class I molecules. Mutations and/or polymorphism within these genes could alter the efficacy of the immune response which might be relevant for the development of autoimmune diseases and cancer. METHODS: DNA was isolated from peripheral blood sample of 200 patients with cervical cancer and 200 healthy controls. TAP1 and TAP2 allele polymorphism were determined by polymerase chain reaction. RESULT: Significant protective OR (OR = 0.22 95% CI = 0.09-0.51, P < 0.001-OR = 0.47, 95% CI = 0.24-0.92, P = 0.02) was observed for GG and combined AG+GG genotypes of TAP2 in patients with SCC respectively. Similarly, such genotypes (GG, AG+GG) appeared same OR for patient with cervical cancer in study group (OR = 0.12, 95% CI = 0.04-0.39-P < 0.001-OR = 0.5 ,95% CI = 0.25-0.95-P = 0.03). There was decrease risk of cervical cancer in user of oral contraceptive with AG and GG genotypes of TAP2 (OR = 0.55, 95% Cl = 0.41-0.73, P = 0.002, OR = 0.09, 95% CI = 0.02-0.36, P < 0.001) respectively. In case of TAP1 gene all allelic polymorphisms showed a decrease OR in patients with cervical cancer in passive smokers and user of oral contraceptives, though, no significant CONCLUSION: Thus, TAP1 and TAP2 genes polymorphism are not linked to cervical carcinoma, since no association was found between a particular genotype and the disease.
机译:背景:与抗原加工相关的转运蛋白(TAP)是ATP结合盒转运蛋白超家族的成员,由两个完整的膜蛋白TAP-1和TAP-2组成。 TAP基因产物参与与MHC I类分子结合的内源肽的加工。这些基因内的突变和/或多态性可能会改变免疫反应的功效,这可能与自身免疫性疾病和癌症的发生有关。方法:从200例宫颈癌患者和200例健康对照者的外周血样本中分离DNA。通过聚合酶链反应确定TAP1和TAP2等位基因多态性。结果:在GG和TAP2的AG + GG基因型联合中,观察到了显着的保护性OR(OR = 0.22 95%CI = 0.09-0.51,P <0.001-OR = 0.47,95%CI = 0.24-0.92,P = 0.02)。 SCC患者分别。同样,研究组宫颈癌患者的这种基因型(GG,AG + GG)表现相同(OR = 0.12,95%CI = 0.04-0.39-P <0.001-OR = 0.5,95%CI = 0.25-0.95 -P = 0.03)。 AG和GG基因型的TAP2口服避孕药的患子宫颈癌的风险降低(OR = 0.55,95%Cl = 0.41-0.73,P = 0.002,OR = 0.09,95%CI = 0.02-0.36,P < 0.001)。对于TAP1基因,在被动吸烟者和口服避孕药的宫颈癌患者中,所有等位基因多态性均显示OR降低,但无显着结论。因此,TAP1和TAP2基因多态性与宫颈癌无关,因为两者之间没有关联。发现在特定的基因型和疾病之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号